Beoung Hun Lee, Suhn K Rhie. Epigenetics Chromatin 2021
Times Cited: 2
Times Cited: 2
Times Cited
Times Co-cited
Similarity
Comprehensive analysis of CpG islands in human chromosomes 21 and 22.
Daiya Takai, Peter A Jones. Proc Natl Acad Sci U S A 2002
Daiya Takai, Peter A Jones. Proc Natl Acad Sci U S A 2002
50
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.
Hyuna Sung, Jacques Ferlay, Rebecca L Siegel, Mathieu Laversanne, Isabelle Soerjomataram, Ahmedin Jemal, Freddie Bray. CA Cancer J Clin 2021
Hyuna Sung, Jacques Ferlay, Rebecca L Siegel, Mathieu Laversanne, Isabelle Soerjomataram, Ahmedin Jemal, Freddie Bray. CA Cancer J Clin 2021
50
Most mammalian mRNAs are conserved targets of microRNAs.
Robin C Friedman, Kyle Kai-How Farh, Christopher B Burge, David P Bartel. Genome Res 2009
Robin C Friedman, Kyle Kai-How Farh, Christopher B Burge, David P Bartel. Genome Res 2009
50
A genomic sequencing protocol that yields a positive display of 5-methylcytosine residues in individual DNA strands.
M Frommer, L E McDonald, D S Millar, C M Collis, F Watt, G W Grigg, P L Molloy, C L Paul. Proc Natl Acad Sci U S A 1992
M Frommer, L E McDonald, D S Millar, C M Collis, F Watt, G W Grigg, P L Molloy, C L Paul. Proc Natl Acad Sci U S A 1992
50
High-throughput single-cell ChIP-seq identifies heterogeneity of chromatin states in breast cancer.
Kevin Grosselin, Adeline Durand, Justine Marsolier, Adeline Poitou, Elisabetta Marangoni, Fariba Nemati, Ahmed Dahmani, Sonia Lameiras, Fabien Reyal, Olivia Frenoy,[...]. Nat Genet 2019
Kevin Grosselin, Adeline Durand, Justine Marsolier, Adeline Poitou, Elisabetta Marangoni, Fariba Nemati, Ahmed Dahmani, Sonia Lameiras, Fabien Reyal, Olivia Frenoy,[...]. Nat Genet 2019
50
Novel treatment strategies in triple-negative breast cancer: specific role of poly(adenosine diphosphate-ribose) polymerase inhibition.
M William Audeh. Pharmgenomics Pers Med 2014
M William Audeh. Pharmgenomics Pers Med 2014
50
Plasma ESR1 Mutations and the Treatment of Estrogen Receptor-Positive Advanced Breast Cancer.
Charlotte Fribbens, Ben O'Leary, Lucy Kilburn, Sarah Hrebien, Isaac Garcia-Murillas, Matthew Beaney, Massimo Cristofanilli, Fabrice Andre, Sherene Loi, Sibylle Loibl,[...]. J Clin Oncol 2016
Charlotte Fribbens, Ben O'Leary, Lucy Kilburn, Sarah Hrebien, Isaac Garcia-Murillas, Matthew Beaney, Massimo Cristofanilli, Fabrice Andre, Sherene Loi, Sibylle Loibl,[...]. J Clin Oncol 2016
50
Tucidinostat plus exemestane for postmenopausal patients with advanced, hormone receptor-positive breast cancer (ACE): a randomised, double-blind, placebo-controlled, phase 3 trial.
Zefei Jiang, Wei Li, Xichun Hu, Qingyuan Zhang, Tao Sun, Shude Cui, Shusen Wang, Quchang Ouyang, Yongmei Yin, Cuizhi Geng,[...]. Lancet Oncol 2019
Zefei Jiang, Wei Li, Xichun Hu, Qingyuan Zhang, Tao Sun, Shude Cui, Shusen Wang, Quchang Ouyang, Yongmei Yin, Cuizhi Geng,[...]. Lancet Oncol 2019
50
Pharmacogenomics: the genetics of variable drug responses.
Dan M Roden, Russell A Wilke, Heyo K Kroemer, C Michael Stein. Circulation 2011
Dan M Roden, Russell A Wilke, Heyo K Kroemer, C Michael Stein. Circulation 2011
50
Single-cell ChIP-seq reveals cell subpopulations defined by chromatin state.
Assaf Rotem, Oren Ram, Noam Shoresh, Ralph A Sperling, Alon Goren, David A Weitz, Bradley E Bernstein. Nat Biotechnol 2015
Assaf Rotem, Oren Ram, Noam Shoresh, Ralph A Sperling, Alon Goren, David A Weitz, Bradley E Bernstein. Nat Biotechnol 2015
50
Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications.
T Sørlie, C M Perou, R Tibshirani, T Aas, S Geisler, H Johnsen, T Hastie, M B Eisen, M van de Rijn, S S Jeffrey,[...]. Proc Natl Acad Sci U S A 2001
T Sørlie, C M Perou, R Tibshirani, T Aas, S Geisler, H Johnsen, T Hastie, M B Eisen, M van de Rijn, S S Jeffrey,[...]. Proc Natl Acad Sci U S A 2001
50
An evaluation of new criteria for CpG islands in the human genome as gene markers.
Yong Wang, Frederick C C Leung. Bioinformatics 2004
Yong Wang, Frederick C C Leung. Bioinformatics 2004
50
Triple-negative breast cancer molecular subtyping and treatment progress.
Li Yin, Jiang-Jie Duan, Xiu-Wu Bian, Shi-Cang Yu. Breast Cancer Res 2020
Li Yin, Jiang-Jie Duan, Xiu-Wu Bian, Shi-Cang Yu. Breast Cancer Res 2020
50
Whole genome sequencing identifies high-impact variants in well-known pharmacogenomic genes.
Jihoon Choi, Kelan G Tantisira, Qing Ling Duan. Pharmacogenomics J 2019
Jihoon Choi, Kelan G Tantisira, Qing Ling Duan. Pharmacogenomics J 2019
50
Functional and prognostic significance of long non-coding RNA MALAT1 as a metastasis driver in ER negative lymph node negative breast cancer.
Mahdieh Jadaliha, Xinying Zong, Pushkar Malakar, Tania Ray, Deepak K Singh, Susan M Freier, Tor Jensen, Supriya G Prasanth, Rotem Karni, Partha S Ray,[...]. Oncotarget 2016
Mahdieh Jadaliha, Xinying Zong, Pushkar Malakar, Tania Ray, Deepak K Singh, Susan M Freier, Tor Jensen, Supriya G Prasanth, Rotem Karni, Partha S Ray,[...]. Oncotarget 2016
50
Single-cell chromatin immunocleavage sequencing (scChIC-seq) to profile histone modification.
Wai Lim Ku, Kosuke Nakamura, Weiwu Gao, Kairong Cui, Gangqing Hu, Qingsong Tang, Bing Ni, Keji Zhao. Nat Methods 2019
Wai Lim Ku, Kosuke Nakamura, Weiwu Gao, Kairong Cui, Gangqing Hu, Qingsong Tang, Bing Ni, Keji Zhao. Nat Methods 2019
50
Human Epidermal Growth Factor Receptor 2 (HER2) in Cancers: Overexpression and Therapeutic Implications.
Nida Iqbal, Naveed Iqbal. Mol Biol Int 2014
Nida Iqbal, Naveed Iqbal. Mol Biol Int 2014
50
Recent Advances in the Treatment of Breast Cancer.
Christy W S Tong, Mingxia Wu, William C S Cho, Kenneth K W To. Front Oncol 2018
Christy W S Tong, Mingxia Wu, William C S Cho, Kenneth K W To. Front Oncol 2018
50
Methods for ChIP-seq analysis: A practical workflow and advanced applications.
Ryuichiro Nakato, Toyonori Sakata. Methods 2021
Ryuichiro Nakato, Toyonori Sakata. Methods 2021
50
Germline Mutation Status, Pathological Complete Response, and Disease-Free Survival in Triple-Negative Breast Cancer: Secondary Analysis of the GeparSixto Randomized Clinical Trial.
Eric Hahnen, Bianca Lederer, Jan Hauke, Sibylle Loibl, Sandra Kröber, Andreas Schneeweiss, Carsten Denkert, Peter A Fasching, Jens U Blohmer, Christian Jackisch,[...]. JAMA Oncol 2017
Eric Hahnen, Bianca Lederer, Jan Hauke, Sibylle Loibl, Sandra Kröber, Andreas Schneeweiss, Carsten Denkert, Peter A Fasching, Jens U Blohmer, Christian Jackisch,[...]. JAMA Oncol 2017
50
Alteration of Epigenetic Regulation by Long Noncoding RNAs in Cancer.
Mariangela Morlando, Alessandro Fatica. Int J Mol Sci 2018
Mariangela Morlando, Alessandro Fatica. Int J Mol Sci 2018
50
miR-23b and miR-27b are oncogenic microRNAs in breast cancer: evidence from a CRISPR/Cas9 deletion study.
Bethany N Hannafon, Angela Cai, Cameron L Calloway, Yi-Fan Xu, Roy Zhang, Kar-Ming Fung, Wei-Qun Ding. BMC Cancer 2019
Bethany N Hannafon, Angela Cai, Cameron L Calloway, Yi-Fan Xu, Roy Zhang, Kar-Ming Fung, Wei-Qun Ding. BMC Cancer 2019
50
Mechanisms of resistance to endocrine therapy in breast cancer: focus on signaling pathways, miRNAs and genetically based resistance.
Rocío García-Becerra, Nancy Santos, Lorenza Díaz, Javier Camacho. Int J Mol Sci 2012
Rocío García-Becerra, Nancy Santos, Lorenza Díaz, Javier Camacho. Int J Mol Sci 2012
50
HER2-directed therapy: current treatment options for HER2-positive breast cancer.
Shahid Ahmed, Amer Sami, Jim Xiang. Breast Cancer 2015
Shahid Ahmed, Amer Sami, Jim Xiang. Breast Cancer 2015
50
A chromatin integration labelling method enables epigenomic profiling with lower input.
Akihito Harada, Kazumitsu Maehara, Tetsuya Handa, Yasuhiro Arimura, Jumpei Nogami, Yoko Hayashi-Takanaka, Katsuhiko Shirahige, Hitoshi Kurumizaka, Hiroshi Kimura, Yasuyuki Ohkawa. Nat Cell Biol 2019
Akihito Harada, Kazumitsu Maehara, Tetsuya Handa, Yasuhiro Arimura, Jumpei Nogami, Yoko Hayashi-Takanaka, Katsuhiko Shirahige, Hitoshi Kurumizaka, Hiroshi Kimura, Yasuyuki Ohkawa. Nat Cell Biol 2019
50
The long non-coding RNA landscape in triple-negative breast cancer.
Wenwen Zhang, Xiaoxiang Guan, Jinhai Tang. Cell Prolif 2021
Wenwen Zhang, Xiaoxiang Guan, Jinhai Tang. Cell Prolif 2021
50
An efficient targeted nuclease strategy for high-resolution mapping of DNA binding sites.
Peter J Skene, Steven Henikoff. Elife 2017
Peter J Skene, Steven Henikoff. Elife 2017
50
The NHGRI-EBI GWAS Catalog of published genome-wide association studies, targeted arrays and summary statistics 2019.
Annalisa Buniello, Jacqueline A L MacArthur, Maria Cerezo, Laura W Harris, James Hayhurst, Cinzia Malangone, Aoife McMahon, Joannella Morales, Edward Mountjoy, Elliot Sollis,[...]. Nucleic Acids Res 2019
Annalisa Buniello, Jacqueline A L MacArthur, Maria Cerezo, Laura W Harris, James Hayhurst, Cinzia Malangone, Aoife McMahon, Joannella Morales, Edward Mountjoy, Elliot Sollis,[...]. Nucleic Acids Res 2019
50
Metabolism and transport of tamoxifen in relation to its effectiveness: new perspectives on an ongoing controversy.
Deirdre P Cronin-Fenton, Per Damkier, Timothy L Lash. Future Oncol 2014
Deirdre P Cronin-Fenton, Per Damkier, Timothy L Lash. Future Oncol 2014
50
50
Chromatin modifiers and remodellers: regulators of cellular differentiation.
Taiping Chen, Sharon Y R Dent. Nat Rev Genet 2014
Taiping Chen, Sharon Y R Dent. Nat Rev Genet 2014
50
Pharmacogenomics of breast cancer therapy: an update.
Kelly Westbrook, Vered Stearns. Pharmacol Ther 2013
Kelly Westbrook, Vered Stearns. Pharmacol Ther 2013
50
Moving towards individualized medicine with pharmacogenomics.
William E Evans, Mary V Relling. Nature 2004
William E Evans, Mary V Relling. Nature 2004
50
The endogenous retrovirus-derived long noncoding RNA TROJAN promotes triple-negative breast cancer progression via ZMYND8 degradation.
Xi Jin, Xiao-En Xu, Yi-Zhou Jiang, Yi-Rong Liu, Wei Sun, Ya-Jie Guo, Yi-Xing Ren, Wen-Jia Zuo, Xin Hu, Sheng-Lin Huang,[...]. Sci Adv 2019
Xi Jin, Xiao-En Xu, Yi-Zhou Jiang, Yi-Rong Liu, Wei Sun, Ya-Jie Guo, Yi-Xing Ren, Wen-Jia Zuo, Xin Hu, Sheng-Lin Huang,[...]. Sci Adv 2019
50
Noncoding RNA therapeutics - challenges and potential solutions.
Melanie Winkle, Sherien M El-Daly, Muller Fabbri, George A Calin. Nat Rev Drug Discov 2021
Melanie Winkle, Sherien M El-Daly, Muller Fabbri, George A Calin. Nat Rev Drug Discov 2021
50
Epi-drugs as triple-negative breast cancer treatment.
Mouhamed Idrissou, Anna Sanchez, Frédérique Penault-Llorca, Yves-Jean Bignon, Dominique Bernard-Gallon. Epigenomics 2020
Mouhamed Idrissou, Anna Sanchez, Frédérique Penault-Llorca, Yves-Jean Bignon, Dominique Bernard-Gallon. Epigenomics 2020
50
Systemic Delivery of Tumor-Targeting siRNA Nanoparticles against an Oncogenic LncRNA Facilitates Effective Triple-Negative Breast Cancer Therapy.
Amita M Vaidya, Zhanhu Sun, Nadia Ayat, Andrew Schilb, Xujie Liu, Hongfa Jiang, Da Sun, Josef Scheidt, Victoria Qian, Siyuan He,[...]. Bioconjug Chem 2019
Amita M Vaidya, Zhanhu Sun, Nadia Ayat, Andrew Schilb, Xujie Liu, Hongfa Jiang, Da Sun, Josef Scheidt, Victoria Qian, Siyuan He,[...]. Bioconjug Chem 2019
50
Health-promoting role of dietary bioactive compounds through epigenetic modulations: a novel prophylactic and therapeutic approach.
Ankita Kumari, Shalaka Bhawal, Suman Kapila, Hariom Yadav, Rajeev Kapila. Crit Rev Food Sci Nutr 2022
Ankita Kumari, Shalaka Bhawal, Suman Kapila, Hariom Yadav, Rajeev Kapila. Crit Rev Food Sci Nutr 2022
50
Translating pharmacogenomics into clinical decisions: do not let the perfect be the enemy of the good.
Kristi Krebs, Lili Milani. Hum Genomics 2019
Kristi Krebs, Lili Milani. Hum Genomics 2019
50
Accessing genetic variation: genotyping single nucleotide polymorphisms.
A C Syvänen. Nat Rev Genet 2001
A C Syvänen. Nat Rev Genet 2001
50
Mechanisms of Chemotherapy Resistance in Triple-Negative Breast Cancer-How We Can Rise to the Challenge.
Milica Nedeljković, Ana Damjanović. Cells 2019
Milica Nedeljković, Ana Damjanović. Cells 2019
50
Identification of essential genes for cancer immunotherapy.
Shashank J Patel, Neville E Sanjana, Rigel J Kishton, Arash Eidizadeh, Suman K Vodnala, Maggie Cam, Jared J Gartner, Li Jia, Seth M Steinberg, Tori N Yamamoto,[...]. Nature 2017
Shashank J Patel, Neville E Sanjana, Rigel J Kishton, Arash Eidizadeh, Suman K Vodnala, Maggie Cam, Jared J Gartner, Li Jia, Seth M Steinberg, Tori N Yamamoto,[...]. Nature 2017
50
Specific breast cancer prognosis-subtype distinctions based on DNA methylation patterns.
Shumei Zhang, Yihan Wang, Yue Gu, Jiang Zhu, Ce Ci, Zhongfu Guo, Chuangeng Chen, Yanjun Wei, Wenhua Lv, Hongbo Liu,[...]. Mol Oncol 2018
Shumei Zhang, Yihan Wang, Yue Gu, Jiang Zhu, Ce Ci, Zhongfu Guo, Chuangeng Chen, Yanjun Wei, Wenhua Lv, Hongbo Liu,[...]. Mol Oncol 2018
50
Emerging roles of long non-coding RNAs in breast cancer biology and management.
I Amelio, F Bernassola, E Candi. Semin Cancer Biol 2021
I Amelio, F Bernassola, E Candi. Semin Cancer Biol 2021
50
MicroRNAs in breast cancer: Roles, functions, and mechanism of actions.
Maryam Abolghasemi, Sadra Samavarchi Tehrani, Tooba Yousefi, Ansar Karimian, Ata Mahmoodpoor, Aliakbar Ghamari, Farhad Jadidi-Niaragh, Mehdi Yousefi, Hossein Samadi Kafil, Milad Bastami,[...]. J Cell Physiol 2020
Maryam Abolghasemi, Sadra Samavarchi Tehrani, Tooba Yousefi, Ansar Karimian, Ata Mahmoodpoor, Aliakbar Ghamari, Farhad Jadidi-Niaragh, Mehdi Yousefi, Hossein Samadi Kafil, Milad Bastami,[...]. J Cell Physiol 2020
50
Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.